News and Opinions - World Stem Cell Summit

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by admin | Jul 15, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Science Daily News – CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response. Source: Stanford Medicine. Click Here to read the...

CAR T cell therapy for pediatric brain cancer warrants further study

by admin | Jul 12, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Baylor College of Medicine – Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy using...

J.P. Morgan’s private financing arm closes inaugural 0M-plus biotech fund

J.P. Morgan’s private financing arm closes inaugural $500M-plus biotech fund

by admin | Jul 11, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Gabrielle Masson – Fierce Biothech – J.P. Morgan Private Capital has closed an inaugural life sciences fund of more than $500 million, cash that will go toward a wide range of private biotechs and build value for existing portfolio companies. Dubbed the...

Eyesight from a 3D Printer

by admin | Jul 10, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Karlsruhe Institute of Technology – KIT Researchers and Industry Partners Develop Process for Printing Personalized Corneas; Project Wins NEULAND Innovation Contest Printing a new cornea during an operation to restore a patient’s eyesight: This groundbreaking...

Growth factors linked to stem cell aging in bone marrow study

by admin | Jul 9, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Jackson Laboratory – Medical Express – Our bone marrow—the fatty, jelly-like substance inside our bones—is an unseen powerhouse quietly producing 500 billion new blood cells every day. That process is driven by hematopoietic stem cells that generate all...

Stem cell therapy for interstitial cystitis/bladder pain syndrome

by admin | Jul 8, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By PubMed – The analysis on phase 1/2a trial which had several modifications in protocol is currently ongoing. Despite several limitations that need to be overcome, stem cell therapy could be a potential therapeutic option for treating IC/BPS. Clinical outcome...